FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
IPO Status: Listed [16th Jul 2021 to 20th Jul 2021]
We have captured total 10 recommendations for Tatva Chintan Pharma IPO. Out of 10 , 8 financial institutes/analysts have given rating for Subscribe, 0 for May Apply (50-50), 0 for Avoid and 0 hasn't given any rating. In terms of percentage 80% institutes has rated Tatva Chintan Pharma IPO for subscribe.
Here we have covered Tatva Chintan Pharma IPO Notes from Research Analysts and provided you their recommendations. These research notes will give you 360 degree view of Tatva Chintan Pharma IPO. Some research analysts give clear recommendations and some left decision on you with complete analysis. We try to add the information as on when we receive the document.
Zerodha Trade@20
Tatva Chintan Pharma IPO details includes issue size, issue price, discount information, minimum and maximum order quantity, promoters holding details, NSE and BSE code.
IPO Details | Values |
---|---|
IPO IPO Open Date | 16th Jul 2021 |
IPO IPO Close Date | 20th Jul 2021 |
IPO Issue Size | ₹500 Cr |
IPO Issue Price | ₹1073-1083 |
Market Lot | 13 Shares |
Latest and updated information about Tatva Chintan Pharma IPO. Dates are updated as they are announced.
IPO Activity | Date |
---|---|
IPO IPO Open Date | 16th Jul 2021 |
IPO IPO Close Date | 20th Jul 2021 |
Basis of Allotment Finalisation Date* | 26th Jul 2021 |
Refunds Initiation* | 27th Jul 2021 |
Credit of Shares to Demat Account* | 28th Jul 2021 |
IPO Listing Date* | 29th Jul 2021 |
* - Tentative Dates
Last Updated on 2021-09-27T10:40:21+00:00